Publications by authors named "Johan Palm"

Claim this Profile
L
Leveraging Biopharmaceutics Bridging Risk Assessment and In Vivo Predictive Tools to Accelerate Immediate Release Drug Product Development by Minimized Need for Clinical Bridging Studies.
Helena Engman, Sara Carlert, Maria Hammarberg, Richard Barker, James Mann, Johan Palm

Mol Pharm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrinsic lipolysis rate for systematic design of lipid-based formulations.
Ann-Christin Jacobsen, Aleksei Kabedev, Patrick D Sinko, Johan E Palm, Christel A S Bergström

Drug Deliv Transl Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Tribute to Professor Per Artursson - Scientist, Explorer, Mentor, Innovator, and Giant in Pharmaceutical Research.
Pär Matsson, Pawel Baranczewski, Kathleen M Giacomini, Tommy B Andersson, Johan Palm, Katrin Palm

J Pharm Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenapanor administration and the activity of the H -coupled transporter PepT1 in healthy volunteers.
Susanne Johansson, David P Rosenbaum, Johan Palm, Bergur Stefansson, Mikael Knutsson

Br J Clin Pharmacol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substrate and method dependent inhibition of three ABC-transporters (MDR1, BCRP, and MRP2).
Jenny M Pedersen, Elin K Khan, Christel A S Bergström, Johan Palm, Janet Hoogstraate

Eur J Pharm Sci· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Input Estimation for Extended-Release Formulations Exemplified with Exenatide.
Magnus Trägårdh, Michael J Chappell, Johan E Palm, Neil D Evans, David L I Janzén

Front Bioeng Biotechnol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined in vitro-in vivo approach to assess the hepatobiliary disposition of a novel oral thrombin inhibitor.
Elin M Matsson, Ulf G Eriksson, Johan E Palm, Per Artursson, Maria Karlgren

Mol Pharm· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteria.
Joe Bentz, Michael P O'Connor, Dallas Bednarczyk, Joann Coleman, Caroline Lee, Johan Palm

Drug Metab Dispos· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of receiver operating characteristic analysis to refine the prediction of potential digoxin drug interactions.
Harma Ellens, Shibing Deng, Joann Coleman, Joe Bentz, Mitchell E Taub, Johan Palm

Drug Metab Dispos· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A P-gp vesicular transport inhibition assay - optimization and validation for drug-drug interaction testing.
Krisztina Herédi-Szabó, Johan E Palm, Tommy B Andersson, Ákos Pál, Dóra Méhn

Eur J Pharm Sci· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions.
Maria Karlgren, Gustav Ahlin, Christel A S Bergström, Richard Svensson, Johan Palm

Pharm Res· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a highly sensitive method using liquid chromatography-multiple reaction monitoring to quantify membrane P-glycoprotein in biological matrices and relationship to transport function.
Tasso Miliotis, Liaqat Ali, Johan E Palm, Anders J Lundqvist, Martin Ahnoff

Drug Metab Dispos· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of ketoconazole on the in vivo biotransformation and hepatobiliary transport of the thrombin inhibitor AZD0837 in pigs.
Elin M Matsson, Johan E Palm, Ulf G Eriksson, Pernilla Bottner, Anna Lundahl

Drug Metab Dispos· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis